Shuttle Pharmaceuticals Holdings, Inc. SHPH
5.21 USD +0.06 (+1.17%)
At closeNov 4, 2026, 4:00 PM EST
5.21 0.00 0.00%
After hours · Nov 4, 4:00 PM ET
5.07 Day range 5.39
2.58 52-week range 44.40
- YTD
- -71.06%
- 1 year
- -81.97%
Financial health
Altman Z-Score
-0.77 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
1 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
B-2 / 5 overall
- DCF 2
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 4
- P/E 1
- P/B 5
Valuation
P/E -0.3×
FY 2017 5y median -222× FY 2025
P/S 0.0×
FY 2017 5y median 0.0× FY 2025
P/B 1.3×
FY 2017 5y median 313× FY 2025
P/FCF -0.3×
FY 2017 5y median -259× FY 2025
EV/EBITDA -0.3×
FY 2017 5y median -362× FY 2025
EV/Sales 0.0×
FY 2017 5y median 0.0× FY 2025
FCF Yield -321.6%
FY 2017 5y median -0.4% FY 2025
Profitability
Gross Margin 0.0%
FY 2017 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2017 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2017 5y median 0.0% FY 2025
ROE -519.9%
FY 2017 5y median -162.6% FY 2025
ROIC -460.8%
FY 2017 5y median -106.0% FY 2025
ROA -111.9%
FY 2017 5y median -111.9% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2017 FY 2025
Operating Income -54.8%
FY 2017 FY 2025
EPS (diluted) 99.2%
FY 2017 FY 2025
Free Cash Flow -29.4%
FY 2017 FY 2025
Financial Health
Current Ratio 0.1×
FY 2017 5y median 1.4× FY 2025
Quick Ratio 0.1×
FY 2017 5y median 1.4× FY 2025
Debt / Equity 0.1×
FY 2017 5y median 0.1× FY 2025
Net Debt / EBITDA 0.0×
FY 2017 5y median 0.1× FY 2025
Interest Coverage -168×
FY 2017 5y median -5.7× FY 2025
Dividends
Dividend Yield 0.0%
FY 2017 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2017 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31